<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p45" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_45{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_45{left:341px;bottom:30px;}
#t3_45{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_45{left:377px;bottom:30px;}
#t5_45{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_45{left:540px;bottom:30px;}
#t7_45{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_45{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_45{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_45{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_45{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_45{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_45{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_45{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_45{left:1111px;bottom:28px;letter-spacing:0.1px;}
#tg_45{left:1068px;bottom:422px;letter-spacing:-0.1px;}
#th_45{left:1068px;bottom:404px;letter-spacing:-0.09px;}
#ti_45{left:1068px;bottom:385px;letter-spacing:-0.08px;}
#tj_45{left:1068px;bottom:336px;letter-spacing:-0.09px;}
#tk_45{left:1068px;bottom:317px;letter-spacing:-0.06px;}
#tl_45{left:1068px;bottom:299px;letter-spacing:-0.08px;}
#tm_45{left:1068px;bottom:281px;letter-spacing:-0.09px;}
#tn_45{left:1068px;bottom:262px;letter-spacing:-0.42px;}
#to_45{left:36px;bottom:542px;letter-spacing:-0.1px;}
#tp_45{left:36px;bottom:524px;letter-spacing:-0.07px;}
#tq_45{left:36px;bottom:505px;letter-spacing:-0.09px;}
#tr_45{left:36px;bottom:487px;letter-spacing:-0.12px;}
#ts_45{left:36px;bottom:469px;letter-spacing:-0.1px;}
#tt_45{left:97px;bottom:476px;letter-spacing:-0.15px;}
#tu_45{left:34px;bottom:183px;}
#tv_45{left:40px;bottom:177px;letter-spacing:0.1px;word-spacing:-0.04px;}
#tw_45{left:322px;bottom:177px;}
#tx_45{left:34px;bottom:166px;}
#ty_45{left:43px;bottom:160px;letter-spacing:0.13px;}
#tz_45{left:258px;bottom:160px;}
#t10_45{left:34px;bottom:149px;}
#t11_45{left:40px;bottom:143px;letter-spacing:0.11px;word-spacing:0.01px;}
#t12_45{left:43px;bottom:127px;letter-spacing:0.12px;}
#t13_45{left:43px;bottom:110px;letter-spacing:0.12px;}
#t14_45{left:181px;bottom:110px;letter-spacing:0.13px;}
#t15_45{left:265px;bottom:110px;}
#t16_45{left:185px;bottom:778px;letter-spacing:0.46px;}
#t17_45{left:185px;bottom:760px;letter-spacing:0.45px;}
#t18_45{left:184px;bottom:692px;letter-spacing:-0.09px;}
#t19_45{left:184px;bottom:673px;letter-spacing:-0.14px;}
#t1a_45{left:184px;bottom:512px;letter-spacing:-0.09px;}
#t1b_45{left:184px;bottom:493px;letter-spacing:-0.14px;}
#t1c_45{left:184px;bottom:320px;letter-spacing:-0.09px;}
#t1d_45{left:184px;bottom:301px;letter-spacing:-0.11px;}
#t1e_45{left:341px;bottom:692px;letter-spacing:-0.1px;}
#t1f_45{left:445px;bottom:699px;}
#t1g_45{left:341px;bottom:673px;letter-spacing:-0.09px;}
#t1h_45{left:341px;bottom:552px;letter-spacing:-0.13px;}
#t1i_45{left:365px;bottom:559px;}
#t1j_45{left:341px;bottom:534px;letter-spacing:-0.08px;}
#t1k_45{left:341px;bottom:515px;letter-spacing:-0.1px;}
#t1l_45{left:341px;bottom:497px;letter-spacing:-0.09px;}
#t1m_45{left:341px;bottom:479px;letter-spacing:-0.1px;}
#t1n_45{left:430px;bottom:486px;letter-spacing:-0.12px;}
#t1o_45{left:341px;bottom:460px;letter-spacing:-0.1px;}
#t1p_45{left:337px;bottom:364px;letter-spacing:-0.11px;}
#t1q_45{left:452px;bottom:372px;}
#t1r_45{left:337px;bottom:312px;letter-spacing:-0.1px;}
#t1s_45{left:337px;bottom:261px;letter-spacing:-0.09px;}
#t1t_45{left:337px;bottom:243px;letter-spacing:-0.1px;}
#t1u_45{left:497px;bottom:431px;letter-spacing:-0.1px;}
#t1v_45{left:747px;bottom:438px;}
#t1w_45{left:498px;bottom:336px;letter-spacing:-0.1px;}
#t1x_45{left:498px;bottom:317px;letter-spacing:-0.09px;}
#t1y_45{left:498px;bottom:299px;letter-spacing:-0.09px;}
#t1z_45{left:564px;bottom:307px;}
#t20_45{left:619px;bottom:388px;letter-spacing:-0.09px;}
#t21_45{left:619px;bottom:370px;letter-spacing:-0.09px;}
#t22_45{left:619px;bottom:352px;letter-spacing:-0.1px;}
#t23_45{left:619px;bottom:295px;letter-spacing:-0.08px;}
#t24_45{left:619px;bottom:277px;letter-spacing:-0.09px;}
#t25_45{left:856px;bottom:430px;letter-spacing:-0.13px;}
#t26_45{left:880px;bottom:437px;}
#t27_45{left:828px;bottom:379px;letter-spacing:-0.1px;}
#t28_45{left:828px;bottom:361px;letter-spacing:-0.13px;}
#t29_45{left:852px;bottom:368px;letter-spacing:-0.09px;}
#t2a_45{left:876px;bottom:361px;letter-spacing:-0.09px;}
#t2b_45{left:766px;bottom:305px;letter-spacing:-0.13px;}
#t2c_45{left:789px;bottom:312px;}
#t2d_45{left:766px;bottom:286px;letter-spacing:-0.06px;}
#t2e_45{left:766px;bottom:268px;letter-spacing:-0.26px;}
#t2f_45{left:766px;bottom:250px;letter-spacing:-0.1px;}
#t2g_45{left:855px;bottom:257px;letter-spacing:-0.12px;}
#t2h_45{left:723px;bottom:166px;}
#t2i_45{left:736px;bottom:160px;letter-spacing:0.13px;word-spacing:-0.05px;}
#t2j_45{left:731px;bottom:143px;letter-spacing:0.08px;word-spacing:0.06px;}
#t2k_45{left:857px;bottom:143px;}
#t2l_45{left:723px;bottom:133px;}
#t2m_45{left:733px;bottom:127px;letter-spacing:0.12px;}
#t2n_45{left:732px;bottom:110px;letter-spacing:0.12px;}
#t2o_45{left:945px;bottom:590px;letter-spacing:-0.09px;}
#t2p_45{left:945px;bottom:571px;letter-spacing:-0.09px;}
#t2q_45{left:945px;bottom:553px;letter-spacing:-0.25px;}
#t2r_45{left:516px;bottom:245px;letter-spacing:-0.35px;}
#t2s_45{left:573px;bottom:581px;letter-spacing:-0.1px;}
#t2t_45{left:573px;bottom:560px;letter-spacing:-0.09px;}
#t2u_45{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_45{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_45{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_45{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_45{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_45{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_45{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_45{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s7_45{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s8_45{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s9_45{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.sa_45{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.sb_45{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_45{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sd_45{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts45" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

</style>
<div id="pg45Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg45" style="-webkit-user-select: none;"><object width="1210" height="935" data="45/45.svg" type="image/svg+xml" id="pdf45" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_45" class="t s0_45">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_45" class="t s1_45">® </span>
<span id="t3_45" class="t s0_45">(NCCN </span>
<span id="t4_45" class="t s1_45">® </span>
<span id="t5_45" class="t s0_45">), All rights reserved. NCCN Guidelines </span>
<span id="t6_45" class="t s1_45">® </span>
<span id="t7_45" class="t s0_45">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_45" class="t s2_45">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_45" class="t s2_45">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_45" class="t s3_45">NCCN Guidelines Version 4.2024 </span>
<span id="tb_45" class="t s3_45">Cancer of the Glottic Larynx </span>
<span id="tc_45" class="t s4_45">NCCN Guidelines Index </span>
<span id="td_45" class="t s4_45">Table of Contents </span>
<span id="te_45" class="t s4_45">Discussion </span>
<span id="tf_45" class="t s5_45">GLOT-5 </span>
<span id="tg_45" class="t s5_45">Follow-up </span>
<span id="th_45" class="t s6_45">(FOLL-A, 1 </span>
<span id="ti_45" class="t s6_45">of 2) </span>
<span id="tj_45" class="t s5_45">Recurrent </span>
<span id="tk_45" class="t s5_45">or </span>
<span id="tl_45" class="t s5_45">persistent </span>
<span id="tm_45" class="t s5_45">disease </span>
<span id="tn_45" class="t s6_45">(ADV-3) </span>
<span id="to_45" class="t s5_45">Response </span>
<span id="tp_45" class="t s5_45">after </span>
<span id="tq_45" class="t s5_45">induction </span>
<span id="tr_45" class="t s5_45">chemo- </span>
<span id="ts_45" class="t s5_45">therapy </span>
<span id="tt_45" class="t s7_45">m,p </span>
<span id="tu_45" class="t s8_45">j </span>
<span id="tv_45" class="t s9_45">Principles of Radiation Therapy (GLOT-A)</span><span id="tw_45" class="t sa_45">. </span>
<span id="tx_45" class="t s8_45">k </span>
<span id="ty_45" class="t s9_45">Principles of Surgery (SURG-A)</span><span id="tz_45" class="t sa_45">. </span>
<span id="t10_45" class="t s8_45">l </span>
<span id="t11_45" class="t sa_45">Adverse pathologic features: extranodal extension, positive margins, close margins, pT4 primary, </span>
<span id="t12_45" class="t sa_45">pN2 or pN3 nodal disease, perineural invasion, vascular invasion, lymphatic invasion, and </span>
<span id="t13_45" class="t sa_45">subglottic extension </span><span id="t14_45" class="t s9_45">(Discussion)</span><span id="t15_45" class="t sa_45">. </span>
<span id="t16_45" class="t s5_45">RESPONSE </span>
<span id="t17_45" class="t s5_45">ASSESSMENT </span>
<span id="t18_45" class="t s5_45">Primary site: </span>
<span id="t19_45" class="t s5_45">CR </span>
<span id="t1a_45" class="t s5_45">Primary site: </span>
<span id="t1b_45" class="t s5_45">PR </span>
<span id="t1c_45" class="t s5_45">Primary site: </span>
<span id="t1d_45" class="t s5_45">&lt; PR </span>
<span id="t1e_45" class="t sb_45" data-mappings='[[2,"fi"]]'>Deﬁnitive RT </span>
<span id="t1f_45" class="t s7_45">j </span>
<span id="t1g_45" class="t s5_45">(category 1) </span>
<span id="t1h_45" class="t s5_45">RT </span>
<span id="t1i_45" class="t s7_45">j </span>
<span id="t1j_45" class="t s5_45">(category 1) </span>
<span id="t1k_45" class="t s5_45">or </span>
<span id="t1l_45" class="t s5_45">Systemic </span>
<span id="t1m_45" class="t s5_45">therapy/RT </span>
<span id="t1n_45" class="t s7_45">j,m </span>
<span id="t1o_45" class="t s5_45">(category 2B) </span>
<span id="t1p_45" class="t s5_45">Laryngectomy </span>
<span id="t1q_45" class="t s7_45">k </span>
<span id="t1r_45" class="t s5_45">or </span>
<span id="t1s_45" class="t s5_45">Unresectable </span>
<span id="t1t_45" class="t s5_45">nodal disease </span>
<span id="t1u_45" class="t s5_45">No adverse pathologic features </span>
<span id="t1v_45" class="t s7_45">l </span>
<span id="t1w_45" class="t s5_45">Adverse </span>
<span id="t1x_45" class="t s5_45">pathologic </span>
<span id="t1y_45" class="t s5_45">features </span>
<span id="t1z_45" class="t s7_45">l </span>
<span id="t20_45" class="t s5_45">Extranodal </span>
<span id="t21_45" class="t s5_45">extension and/or </span>
<span id="t22_45" class="t s5_45">positive margin </span>
<span id="t23_45" class="t s5_45">Other risk </span>
<span id="t24_45" class="t s5_45">features </span>
<span id="t25_45" class="t s5_45">RT </span>
<span id="t26_45" class="t s7_45">j </span>
<span id="t27_45" class="t s5_45">Systemic therapy/ </span>
<span id="t28_45" class="t s5_45">RT </span>
<span id="t29_45" class="t s7_45">j,m </span>
<span id="t2a_45" class="t s5_45">(category 1) </span>
<span id="t2b_45" class="t s5_45">RT </span>
<span id="t2c_45" class="t s7_45">j </span>
<span id="t2d_45" class="t s5_45">or </span>
<span id="t2e_45" class="t s5_45">Consider systemic </span>
<span id="t2f_45" class="t s5_45">therapy/RT </span>
<span id="t2g_45" class="t s7_45">j,m </span>
<span id="t2h_45" class="t s8_45">m </span>
<span id="t2i_45" class="t s9_45">Principles of Systemic Therapy for Non-Nasopharyngeal </span>
<span id="t2j_45" class="t s9_45">Cancers (SYST-A)</span><span id="t2k_45" class="t sa_45">. </span>
<span id="t2l_45" class="t s8_45">p </span>
<span id="t2m_45" class="t sc_45">In randomized clinical trials, assessment of response has been </span>
<span id="t2n_45" class="t sa_45">done after 2 or 3 cycles. </span>
<span id="t2o_45" class="t s5_45">Recurrent or </span>
<span id="t2p_45" class="t s5_45">persistent disease </span>
<span id="t2q_45" class="t s6_45">(ADV-3) </span>
<span id="t2r_45" class="t s6_45">ADV-1 </span>
<span id="t2s_45" class="t s6_45">Post Systemic Therapy/RT or RT </span>
<span id="t2t_45" class="t s6_45">Neck Evaluation (FOLL-A, 2 of 2) </span>
<span id="t2u_45" class="t sd_45">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
